by Elena Riboldi (Agenzia Zoe)
Takeaway
- Compared to ipilimumab, Tumour Infiltrating Lymphocytes (TIL) therapy reduced by 50% the chance of progression of the disease or dying from the disease in patients with metastatic melanoma.
Why this matters
- Treatment options for patients with metastatic melanoma failing immune checkpoint inhibitors are...